173 related articles for article (PubMed ID: 11815367)
1. Pharmacological profiles of a novel opioid receptor-like1 (ORL(1)) receptor antagonist, JTC-801.
Yamada H; Nakamoto H; Suzuki Y; Ito T; Aisaka K
Br J Pharmacol; 2002 Jan; 135(2):323-32. PubMed ID: 11815367
[TBL] [Abstract][Full Text] [Related]
2. Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder.
Zhang Y; Simpson-Durand CD; Standifer KM
Br J Pharmacol; 2015 Jan; 172(2):571-82. PubMed ID: 24666365
[TBL] [Abstract][Full Text] [Related]
3. Characterization of nociceptin/orphanin FQ-induced pain responses by the novel receptor antagonist N-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl) benzamide monohydrochloride.
Muratani T; Minami T; Enomoto U; Sakai M; Okuda-Ashitaka E; Kiyokane K; Mori H; Ito S
J Pharmacol Exp Ther; 2002 Oct; 303(1):424-30. PubMed ID: 12235279
[TBL] [Abstract][Full Text] [Related]
4. A new synthetic approach of N-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl)benzamide (JTC-801) and its analogues and their pharmacological evaluation as nociceptin receptor (NOP) antagonists.
Sestili I; Borioni A; Mustazza C; Rodomonte A; Turchetto L; Sbraccia M; Riitano D; Del Giudice MR
Eur J Med Chem; 2004 Dec; 39(12):1047-57. PubMed ID: 15571866
[TBL] [Abstract][Full Text] [Related]
5. 4-Aminoquinolines: novel nociceptin antagonists with analgesic activity.
Shinkai H; Ito T; Iida T; Kitao Y; Yamada H; Uchida I
J Med Chem; 2000 Nov; 43(24):4667-77. PubMed ID: 11101358
[TBL] [Abstract][Full Text] [Related]
6. Helix-constrained nociceptin peptides are potent agonists and antagonists of ORL-1 and nociception.
Lohman RJ; Harrison RS; Ruiz-Gómez G; Hoang HN; Shepherd NE; Chow S; Hill TA; Madala PK; Fairlie DP
Vitam Horm; 2015; 97():1-55. PubMed ID: 25677767
[TBL] [Abstract][Full Text] [Related]
7. JTC-801 alleviates mechanical allodynia in paclitaxel-induced neuropathic pain through the PI3K/Akt pathway.
Huang J; Chen D; Yan F; Wu S; Kang S; Xing W; Zeng W; Xie J
Eur J Pharmacol; 2020 Sep; 883():173306. PubMed ID: 32603693
[TBL] [Abstract][Full Text] [Related]
8. Nociceptin receptor antagonist JTC-801 inhibits nitrous oxide-induced analgesia in mice.
Koyama T; Fukuda K
J Anesth; 2009; 23(2):301-3. PubMed ID: 19444578
[TBL] [Abstract][Full Text] [Related]
9. Anti-allodynic and anti-hyperalgesic effects of nociceptin receptor antagonist, JTC-801, in rats after spinal nerve injury and inflammation.
Tamai H; Sawamura S; Takeda K; Orii R; Hanaoka K
Eur J Pharmacol; 2005 Mar; 510(3):223-8. PubMed ID: 15763246
[TBL] [Abstract][Full Text] [Related]
10. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
[TBL] [Abstract][Full Text] [Related]
11. NOP receptor antagonist, JTC-801, blocks cannabinoid-evoked hypothermia in rats.
Rawls SM; Schroeder JA; Ding Z; Rodriguez T; Zaveri N
Neuropeptides; 2007 Aug; 41(4):239-47. PubMed ID: 17512052
[TBL] [Abstract][Full Text] [Related]
12. Changes in nociceptin/orphanin FQ levels in rat brain regions after acute and chronic cannabinoid treatment in conjunction with the development of antinociceptive tolerance.
Ulugol A; Topuz RD; Gunduz O; Kizilay G; Karadag HC
Fundam Clin Pharmacol; 2016 Dec; 30(6):537-548. PubMed ID: 27371029
[TBL] [Abstract][Full Text] [Related]
13. [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.
Calo G; Rizzi A; Rizzi D; Bigoni R; Guerrini R; Marzola G; Marti M; McDonald J; Morari M; Lambert DG; Salvadori S; Regoli D
Br J Pharmacol; 2002 May; 136(2):303-11. PubMed ID: 12010780
[TBL] [Abstract][Full Text] [Related]
14. Effect of JTC-801 (nociceptin antagonist) on neuropathic pain in a rat model.
Suyama H; Kawamoto M; Gaus S; Yuge O
Neurosci Lett; 2003 Nov; 351(3):133-6. PubMed ID: 14623124
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist.
Ozaki S; Kawamoto H; Itoh Y; Miyaji M; Azuma T; Ichikawa D; Nambu H; Iguchi T; Iwasawa Y; Ohta H
Eur J Pharmacol; 2000 Aug; 402(1-2):45-53. PubMed ID: 10940356
[TBL] [Abstract][Full Text] [Related]
16. Identification of an additional supraspinal component to the analgesic mechanism of action of buprenorphine.
Ding Z; Raffa RB
Br J Pharmacol; 2009 Jul; 157(5):831-43. PubMed ID: 19422392
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies.
Spagnolo B; Carrà G; Fantin M; Fischetti C; Hebbes C; McDonald J; Barnes TA; Rizzi A; Trapella C; Fanton G; Morari M; Lambert DG; Regoli D; Calò G
J Pharmacol Exp Ther; 2007 Jun; 321(3):961-7. PubMed ID: 17329552
[TBL] [Abstract][Full Text] [Related]
18. Synergistic anti-allodynic effects of nociceptin/orphanin FQ and cannabinoid systems in neuropathic mice.
Gunduz O; Karadag HC; Ulugol A
Pharmacol Biochem Behav; 2011 Oct; 99(4):540-4. PubMed ID: 21664922
[TBL] [Abstract][Full Text] [Related]
19. Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors.
Lutfy K; Eitan S; Bryant CD; Yang YC; Saliminejad N; Walwyn W; Kieffer BL; Takeshima H; Carroll FI; Maidment NT; Evans CJ
J Neurosci; 2003 Nov; 23(32):10331-7. PubMed ID: 14614092
[TBL] [Abstract][Full Text] [Related]
20. The opioid peptide nociceptin/orphanin FQ mediates prostaglandin E2-induced allodynia, tactile pain associated with nerve injury.
Okuda-Ashitaka E; Minami T; Matsumura S; Takeshima H; Reinscheid RK; Civelli O; Ito S
Eur J Neurosci; 2006 Feb; 23(4):995-1004. PubMed ID: 16519664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
